PLOD1 promoted proliferation, migration, and invasion of osteosarcoma cells by regulating the Wnt/β-catenin signaling pathway, which indicated PLOD1 might be a potential therapeutic target in osteosarcoma. This evidence concerns the gene PLOD1 and osteosarcoma.